Page last updated: 2024-08-26

3'-azido-3'-deoxy-5'-o-beta-glucopyranuronosylthymidine and Anemia

3'-azido-3'-deoxy-5'-o-beta-glucopyranuronosylthymidine has been researched along with Anemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boucher, FD; Crain, MJ; Elkins, MM; McKinney, R; Mirochnick, M; Modlin, JF; Pelton, S; Ruff, A; Weller, S; Wilfert, C1

Trials

1 trial(s) available for 3'-azido-3'-deoxy-5'-o-beta-glucopyranuronosylthymidine and Anemia

ArticleYear
Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virus.
    The Journal of pediatrics, 1993, Volume: 122, Issue:1

    Topics: Administration, Oral; Anemia; Drug Administration Schedule; Drug Tolerance; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Male; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications, Infectious; Zidovudine

1993